Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446134
Status:
COMPLETED
Last Update Posted:
2012-07-27
First Post:
2007-03-08
Brief Title:
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus HCV
Sponsor:
Bausch Health Americas Inc
Organization:
Bausch Health Americas Inc
Organization Data
Organization:
Bausch Health Americas Inc
Class:
INDUSTRY
Study ID:
RNA003142-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bausch Health Americas Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None